Dr. Paul Parren - Gilde Healthcare

team
Venture&Growth

All team members
Dr. Paul Parren
Operational Partner
The Netherlands

Dr. Paul Parren

Operational Partner

Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved therapeutic antibodies ofatumumab and daratumumab, as well as establishing validated antibody platform technologies. He is a Professor of Molecular Immunology at the Leiden University Medical Center in Leiden, the Netherlands, board member of The Antibody Society and was an Associate Professor at The Scripps Research Institute in La Jolla, California. He holds a PhD in Molecular Immunology from the University of Amsterdam.

Paul assists Gilde in the evaluation of investment opportunities and is also acting as Executive Vice President and Head of Research & Development for Gilde’s portfolio company Lava Therapeutics.

Mika Nishimura

Operational Partner
Mika is a commercialization executive with extensive leadership experience in conceiving, planning, and launching disruptive medical technologies in 50 markets across North America, EMEA, Asia-Pacific, and Latin America.  She has an exceptional track record of...

Marloes Herbrink

Finance Assistant
Marloes Herbrink joined Gilde Healthcare in February 2019. She supports the controller with the daily financial activities. Prior to this Marloes has worked for 20 years for Atradius Collections consecutively as administrative assistant, management assistant...

Karthik Bolisetty

Senior Associate Healthtech
Venture&Growth
Karthik Bolisetty joined Gilde Healthcare in 2023 in the Boston office and focuses on Healthtech. Prior to joining Gilde, Karthik was on the investment team at Northpond Ventures, where he focused primarily on investments in...